April 25, 2020 European Medicines Agency (EMA) has reminded again regarding serious side effects associated with the use of Chloroquine and Hydroxychloroquine in patients suffering from COVID-19. EMA in their bulletin has stated that “Chloroquine and hydroxychloroquine are known to…


April 18, 2020 Central Drugs Standard Control Organization (CDSCO), the Government of India Drug Regulatory Agency has permitted the conduct of clinical trial of Convalescent Plasma In COVID-19 Patients. The trial protocol was developed and submitted by Indian Council of…

Apr 16, 2020 The U.S. Food and Drug Administration approved Jelmyto (mitomycin gel), the first therapy to treat low-grade upper tract urothelial cancer (UTUC). Urothelial cancer is a cancer of the lining of the urinary system. “Although our nation’s…

April 15, 2020 World Health Organization (WHO), the United Nations Health Agency has said that there is no considerable evidence to prove that anti-tuberculosis BCG vaccine protects people against infection with COVID19 virus. WHO in their daily bulletin has…

Apr 9, 2020 The Central Drugs Standard Control Organization, Government of India, has requested all State and Union Territory Drug Controllers to expedite the licensure procedure to manufacture oxygen for medical use. This is considered as a welcome move…
Recent Post
- CDSCO Introduces Online Process for Additional Variant Applications in Cosmetics
- India Imposes National Ban on Nimesulide for Veterinary Use Due to Toxicity Risks
- Major Relief for MSME Pharma Manufacturers: MoHFW Extends Deadline for Revised GMP Compliance
- Pharmacovigilance system compliance in India
- Simplifying Clinical Trial Amendment Approvals in India